If You Invested $10K In American Homes 4 Rent Stock 10 Years Ago, How Much Would You Have Now?

American Homes 4 Rent AMH is a real estate investment trust that acquires, renovates, leases, and operates single-family rental homes.

It is set to report its Q2 2025 earnings on July 31. Wall Street analysts expect the company to post EPS of $0.46, up from $0.45 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $449.74 million, up from $423.49 million a year earlier.

If You Bought AMH Stock 10 Years Ago

The company's stock traded at approximately $16.63 per share 10 years ago. If you had invested $10,000, you could have bought roughly 601 shares. Currently, shares trade at $36.52, meaning your investment's value could have grown to $21,960 from stock price appreciation alone. However, AMH also paid dividends during these 10 years.

Don't Miss:

Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.
Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can invest with $1,000 at just $0.30/share.

AMH's dividend yield is currently 3.29%. Over the last 10 years, it has paid about $4.84 in dividends per share, which means you could have made $2,910 from dividends alone.

Summing up $21,960 and $2,910, we end up with the final value of your investment, which is $24,870. This is how much you could have made if you had invested $10,000 in AMH stock 10 years ago. This means a total return of 148.70%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 238.79%.

What Could The Next 10 Years Bring?

AMH has a consensus rating of "Buy" and a price target of $40.20 based on the ratings of 28 analysts. The price target implies a more than 10% potential upside from the current stock price.

Trending: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential.

The company on May 1 announced its Q1 2025 earnings, posting FFO of $0.46, compared to the consensus estimate of $0.45, and revenues of $459.28 million, compared to the consensus of $448.93 million, as reported by Benzinga.

“As we enter our busy leasing season during a time of economic uncertainty, we continue to have confidence in our strong industry fundamentals and proven business model. Further, with our investment grade balance sheet, diversified portfolio footprint, leading operating platform, and strong resident base, AMH is well-positioned for strength and resiliency,” said CEO Bryan Smith.

For full-year 2025, the company expects core FFO in the range of $1.80 to $1.86 per share.

Check out this article by Benzinga for 11 analysts' insights on AMH.

Given the expected upside potential, growth-focused investors may find AMH stock attractive. Furthermore, they can benefit from the company's solid dividend yield of 3.29%.

Read Next: